Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 December 2025 to question 98754, what his planned timetable is for publication of the packaging change report.

The Medicines and Healthcare products Regulatory Agency (MHRA) published an overview of the completion of the work by the expert working group (EWG) and subsequent advice from the Commission on Human Medicines (CHM) in December 2025 on the MHRA website.

The MHRA has been working with healthcare partner organisations to take forward the recommendations of the EWG and the advice of the CHM. This includes seeking the views of patients with a range of mental health conditions on the proposed updates to the regulatory position for the 28 antidepressants involved in the review in relation to the warnings on suicidal behaviour. The MHRA is ensuring that those who take part receive appropriate safeguarding and signposting, which is required to support their involvement in this work. It is estimated that this user testing will be completed within three months.

It is not possible to confirm the timetable for the publication of the public assessment report until the regulatory position is finalised.